The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Cost-effectiveness of colorectal cancer screening – An overview
Open accessAbstract
There are several modalities available for a colorectal cancer (CRC) screening program. When determining which CRC screening program to implement, the costs of such programs should be considered in comparison to the health benefits they are expected to provide. Cost-effectiveness analysis provides a tool to do this. In this paper we review the evidence on the cost-effectiveness of CRC screening. Published studies universally indicate that when compared with no CRC screening, all screening modalities provide additional years of life at a cost that is deemed acceptable by most industrialized nations. Many recent studies even find CRC screening to be cost-saving. However, when the alternative CRC screening strategies are compared against each other in an incremental cost-effectiveness analysis, no single optimal strategy emerges across the studies. There is consensus that the new technologies of stool DNA testing, computed tomographic colonography and capsule endoscopy are not yet cost-effective compared with the established CRC screening tests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.002 · Cited by 2,990
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,793
Randomised study of screening for colorectal cancer with faecal-occult-blood test
Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03430-7 · Cited by 2,501
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,959
Colorectal cancer screening: Clinical guidelines and rationale
Winawer, S., Fletcher, R., Miller, L., Godlee, F., Stolar, M., Mulrow, C., Woolf, S., Glick, S., Ganiats, T., Bond, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.agast970594 · Cited by 1,612
Screening for Colorectal Cancer
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-5-373 · Cited by 1,200
Whitlock, E. P., Lin, J. S., Liles, E., Beil, T. L., & Fu, R. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00245 · Cited by 845
[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 809
Participation in Colorectal Cancer Screening: A Review
Vernon, S. W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1406 · Cited by 755
van Rossum, L. G., van Rijn, A. F., Laheij, R. J., van Oijen, M. G., Fockens, P., van Krieken, H. H., Verbeek, A. L., Jansen, J. B., & Dekker, E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.040 · Cited by 734
Cost of Care for Elderly Cancer Patients in the United States
Yabroff, K. R., Lamont, E. B., Mariotto, A., Warren, J. L., Topor, M., Meekins, A., & Brown, M. L. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn103 · Cited by 700
A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening
Allison, J. E., Tekawa, I. S., Ransom, L. J., & Adrain, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340304 · Cited by 622
Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer
Sonnenberg, A., Delcò, F., & Inadomi, J. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00007 · Cited by 612
Zauber, A. G., Lansdorp-Vogelaar, I., Knudsen, A. B., Wilschut, J., van Ballegooijen, M., & Kuntz, K. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00244 · Cited by 581
Self-citationPignone, M., Saha, S., Hoerger, T., & Mandelblatt, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00007 · Cited by 538
Hol, L., van Leerdam, M. E., van Ballegooijen, M., van Vuuren, A. J., van Dekken, H., Reijerink, J. C. I. Y., van der Togt, A. C. M., Habbema, J. D. F., & Kuipers, E. J. (2010) · Gut · doi:10.1136/gut.2009.177089 · Cited by 481
Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Wooli, S. H., Glick, S. N., Ganiars, T. G., Bond, J. H., et al. (1997) · Gastroenterology · Cited by 438
The Price Tag on Progress — Chemotherapy for Colorectal Cancer
Schrag, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048143 · Cited by 436
Modifiable risk factors for colon cancer
Giovannucci, E. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(02)00057-2 · Cited by 423
Efficiency measurement of health care: a review of non‐parametric methods and applications
Hollingsworth, B., Dawson, P. J., & Maniadakis, N. (1999) · Health Care Management Science · doi:10.1023/a:1019087828488 · Cited by 413
Allison, J. E., Sakoda, L. C., Levin, T. R., Tucker, J. P., Tekawa, I. S., Cuff, T., Pauly, M. P., Shlager, L., Palitz, A. M., Zhao, W. K., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm150 · Cited by 372
Colorectal Cancer in African Americans
Agrawal, S., Bhupinderjit, A., Bhutani, M. S., Boardman, L., Nguyen, C., Romero, Y., Srinvasan, R., & Figueroa-Moseley, C. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41829.x · Cited by 288
On the decision rules of cost-effectiveness analysis
Johannesson, M., & Weinstein, M. C. (1993) · Journal of Health Economics · doi:10.1016/0167-6296(93)90005-y · Cited by 288
Guittet, L., Bouvier, V, Mariotte, N., Vallee, J. P., Arsène, D., Boutreux, S., Tichet, J., & Launoy, G. (2007) · Gut · doi:10.1136/gut.2006.101428 · Cited by 263
Colorectal Cancer Test Use from the 2005 National Health Interview Survey
Shapiro, J. A., Seeff, L. C., Thompson, T. D., Nadel, M. R., Klabunde, C. N., & Vernon, S. W. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2838 · Cited by 225
Segnan, N., Senore, C., Andreoni, B., Arrigoni, A., Bisanti, L., Cardelli, A., Castiglione, G., Crosta, C., DiPlacido, R., Ferrari, A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji050 · Cited by 194
Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening
Lansdorp-Vogelaar, I., van Ballegooijen, M., Zauber, A. G., Habbema, J. D. F., & Kuipers, E. J. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp319 · Cited by 191
Self-citationThe Personalized Medicine Coalition: Goals and Strategies
Abrahams, E., Ginsburg, G. S., & Silver, M. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505060-00002 · Cited by 180
Kabbinavar, F. F., Hurwitz, H. I., Yi, J., Sarkar, S., & Rosen, O. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7931 · Cited by 180
Brown, M. L., Riley, G. F., Potosky, A. L., & Etzioni, R. D. (1999) · Medical Care · doi:10.1097/00005650-199912000-00008 · Cited by 176
Wide variation in adenoma detection rates at screening flexible sigmoidoscopy
Atkin, W., Rogers, P., Cardwell, C., Cook, C., Cuzick, J., Wardle, J., & Edwards, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.023 · Cited by 175
Hassan, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.7.696 · Cited by 154
How Much Are Americans Willing to Pay for a Quality-Adjusted Life Year?
Weinstein, M. C. (2008) · Medical Care · doi:10.1097/mlr.0b013e31816a7144 · Cited by 153
Fletcher, R. H., Ransohoff, D. F., & Imperiale, T. F. (2007) · Cancer · doi:10.1002/cncr.22611 · Cited by 151
Shaukat, A., Oancea, S. C., Bond, J. H., Church, T. R., & Allen, J. I. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.027 · Cited by 148
Smith, A., Young, G. P., Cole, S. R., et al. (2006) · Cancer · doi:10.1002/cncr.22230 · Cited by 145
Cost - Effectiveness Analysis, Extended Dominance, and Ethics: A Quantitative Assessment
Cantor, S. B. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400308 · Cited by 141
Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine
KALOW, W. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500361 · Cited by 134
Option appraisal of population-based colorectal cancer screening programmes in England
Tappenden, P., Chilcott, J. B., Eggington, S., Sakai, H., Karnon, J. D., & Patnick, J. (2006) · Gut · doi:10.1136/gut.2006.095109 · Cited by 124
Dancourt, V., Lejeune, C., Lepage, C., Gailliard, M. C., Meny, B., & Faivre, J. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.041 · Cited by 102
Parekh, M., Fendrick, A. M., & Ladabaum, U. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03632.x · Cited by 87
Castiglione, G., Zappa, M., Grazzini, G., Mazzotta, A., Biagini, M., Salvadori, P. A., & Ciatto, S. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.329 · Cited by 84
Theuer, C. P., Wagner, J. L., Taylor, T. H., Brewster, W. R., Tran, D., McLaren, C. E., & Anton‐Culver, H. (2001) · Gastroenterology · doi:10.1053/gast.2001.22535 · Cited by 84
Chen, L.-S., Liao, C., Chang, S. H., et al. (2007) · Journal of Medical Screening · doi:10.1258/096914107782912022 · Cited by 75
Tsoi, K. K. F., Ng, S. S. M., LEUNG, M. C. M., & Sung, J. J. �. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0269-2813.2008.03726.x · Cited by 72
Wu, G. H., Wang, Y.-M., Yen, A. M., Wong, J., Lai, H., Warwick, J., & Chen, T. H.-H. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-136 · Cited by 66
Deutekom, M., van Rijn, A. F., Dekker, E., Blaauwgeers, H., Stronks, K., Fockens, P., & Essink‐Bot, M. (2009) · European Journal of Public Health · doi:10.1093/eurpub/ckp051 · Cited by 54
Miglioretti, D. L., Rutter, C. M., Bradford, S. C., Zauber, A. G., Kessler, L. G., Feuer, E. J., & Grossman, D. C. (2008) · Medical Care · doi:10.1097/mlr.0b013e31817946c8 · Cited by 54
Cost-Effectiveness of Colorectal Cancer Screening in the Average Risk Population
Leshno, M., Halpern, Z., & Arber, N. (2003) · Health Care Management Science · doi:10.1023/a:1024488007043 · Cited by 52
Hughes, K. L., Leggett, B., Mar, C. D., Croese, J., Fairley, S. K., Masson, J. W., Aitken, J. F., Clavarino, A. M., Janda, M., Stanton, W. R., et al. (2005) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2005.tb00207.x · Cited by 48
Potential impact of population-based colorectal cancer screening in Canada.
Flanagan, W. M., Petit, C. L., Berthelot, J., White, K. J., Coombs, B. A., & Jones-McLean, E. M. (2003) · PubMed · Cited by 46
Chapter 15: Public Health Policy and Cost-Effectiveness Analysis
Goldie, S. J. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003471 · Cited by 43
Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer
Ag, Z., Lansdorp‐Vogelaar, I., Wilschut, J. A., Ab, K., van Ballegooijen, M., & Kuntz, K. M. (2007) · Europe PMC (PubMed Central) · Cited by 37
Self-citationVisualizing Cost-effectiveness Analysis
Mark, D. (2002) · JAMA · doi:10.1001/jama.287.18.2428 · Cited by 34
Stool DNA Testing and Colon Cancer Prevention: Another Step Forward
Chung, D. C. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-7-200810070-00013 · Cited by 11
Cited by
Health at a glance: OECD indicators
(2010) · Choice Reviews Online · doi:10.5860/choice.47-4774 · Cited by 1,236
Duffy, M. J., Lamerz, R., Haglund, C., Nicolini, A., Kalousová, M., Holubec, L., & Sturgeon, C. (2014) · International Journal of Cancer · doi:10.1002/ijc.28384 · Cited by 360
Artificial Intelligence Allows Leaving-In-Situ Colorectal Polyps
Hassan, C., Balsamo, G., Lorenzetti, R., Zullo, A., & Antonelli, G. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.04.045 · Cited by 119
Metadata
- Authors
- Lansdorp-Vogelaar, I., Knudsen, A. B., & Brenner, H.
- Venue
- Best Practice & Research Clinical Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 24
- Issue
- 4
- Pages
- 439-449
- ISSN
- 1521-6918 (ISSN-L)
- OpenAlex
- W2018449686
- Cited by
- 438
- References
- 57
- FWCI
- 18.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.